Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 9208314, 13 pages
https://doi.org/10.1155/2017/9208314
Research Article

Extracts of Salvia-Nelumbinis Naturalis Ameliorate Nonalcoholic Steatohepatitis via Inhibiting Gut-Derived Endotoxin Mediated TLR4/NF-κB Activation

1Institute of Digestive Diseases, China-Canada Center of Research for Digestive Diseases (ccCRDD), Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
2Department of Biochemistry, Microbiology & Immunology, Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, ON, Canada K1H 8M5

Correspondence should be addressed to Li Zhang; moc.361@lh.ilgnahz

Received 10 March 2017; Revised 1 June 2017; Accepted 18 June 2017; Published 31 July 2017

Academic Editor: H. Balaji Raghavendran

Copyright © 2017 Xiangbing Shu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. M. Younossi, A. B. Koenig, D. Abdelatif, Y. Fazel, L. Henry, and M. Wymer, “Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes,” Hepatology, vol. 64, no. 1, pp. 73–84, 2015. View at Publisher · View at Google Scholar
  2. R. J. Wong, M. Aguilar, R. Cheung et al., “Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States,” Gastroenterology, vol. 148, no. 3, pp. 547–555, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. C. K. Argo, P. G. Northup, A. M. S. Al-Osaimi, and S. H. Caldwell, “Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis,” Journal of Hepatology, vol. 51, no. 2, pp. 371–379, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Ferrere, A. Leroux, L. Wrzosek et al., “Activation of kupffer cells is associated with a specific dysbiosis induced by fructose or high fat diet in mice,” PLoS ONE, vol. 11, no. 1, Article ID e0146177, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Imajo, K. Fujita, M. Yoneda et al., “Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling,” Cell Metabolism, vol. 16, no. 1, pp. 44–54, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Matsushita, T. Osaka, I. Haruta et al., “Effect of lipopolysaccharide on the progression of non-alcoholic fatty liver disease in high caloric diet-fed mice,” Scandinavian Journal of Immunology, vol. 83, no. 2, pp. 109–118, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Sharifnia, J. Antoun, T. G. C. Verriere et al., “Hepatic TLR4 signaling in obese NAFLD,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 309, no. 4, pp. G270–G278, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. J.-Y. Xu, L. Zhang, Z.-P. Li, and G. Ji, “Natural products on nonalcoholic fatty liver disease,” Current Drug Targets, vol. 16, no. 12, pp. 1347–1355, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Pan, M. Wang, H. Song, L. Wang, and G. Ji, “The efficacy and safety of Traditional Chinese Medicine (Jiang Zhi Granule) for nonalcoholic fatty liver: a multicenter, randomized, placebo-controlled study,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 965723, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Zhang, J. Xu, H. Song, Z. Yao, and G. Ji, “Extracts from Salvia-Nelumbinis naturalis alleviate hepatosteatosis via improving hepatic insulin sensitivity,” Journal of Translational Medicine, vol. 12, no. 1, article 236, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Liu, H. Song, L. Wang et al., “Hepatoprotective and antioxidant activities of extracts from Salvia-Nelumbinis naturalis against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet in mice,” Journal of Translational Medicine, vol. 12, no. 1, p. 315, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. Y.-L. Lu, M. Wang, L. Zhang et al., “Simultaneous determination of six components in the 'Jiang-Zhi' granule by UPLC-MS analysis,” Chinese Journal of Natural Medicines, vol. 8, no. 6, pp. 449–455, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Li, X. Shu, H. Xu et al., “Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds,” Journal of Translational Medicine, vol. 14, no. 1, article no. 237, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Zhang, W.-P. Yu, L. Gao, K.-B. Wei, J.-L. Ju, and J.-Z. Xu, “Effects of lipopolysaccharides stimulated Kupffer cells on activation of rat hepatic stellate cells,” World Journal of Gastroenterology, vol. 10, no. 4, pp. 610–613, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. J. S. Park, J. H. Seo, and H.-S. Youn, “Gut microbiota and clinical disease: obesity and nonalcoholic fatty liver disease,” Pediatric Gastroenterology, Hepatology and Nutrition, vol. 16, no. 1, pp. 22–27, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Zhu, R. D. Baker, and S. S. Baker, “Gut microbiome and nonalcoholic fatty liver diseases,” Pediatric Research, vol. 77, pp. 245–251, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Miele, V. Valenza, G. La Torre et al., “Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease,” Hepatology, vol. 49, no. 6, pp. 1877–1887, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Mofidi, H. Poustchi, Z. Yari et al., “Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial,” British Journal of Nutrition, vol. 117, no. 05, pp. 662–668, 2017. View at Publisher · View at Google Scholar
  19. K. Celinski, P. C. Konurek, M. Slomka et al., “Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease - 14 months follow up,” Journal of Physiology and Pharmacology, vol. 65, no. 1, pp. 75–82, 2014. View at Google Scholar · View at Scopus
  20. K. M. Schneider, V. Bieghs, F. Heymann et al., “CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: limiting steatohepatitis by maintaining intestinal homeostasis,” Hepatology, vol. 62, no. 5, pp. 1405–1416, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. R.-Y. Lu, W.-X. Yang, and Y.-J. Hu, “The role of epithelial tight junctions involved in pathogen infections,” Molecular Biology Reports, vol. 41, no. 10, pp. 6591–6610, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. V. W.-S. Wong, G. L.-H. Wong, H.-Y. Chan et al., “Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study,” Alimentary Pharmacology and Therapeutics, vol. 42, no. 6, pp. 731–740, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Ceccarelli, N. Panera, M. Mina et al., “LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease,” Oncotarget, vol. 6, no. 39, pp. 41434–41452, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. J. H. Guo, D. W. Han, L. i. XQ, Y. Zhang, and Y. C. Zhao, “The impact of small doses of LPS on NASH in high sucrose and high fat diet induced rats,” Eur Rev Med Pharmacol Sci, vol. 18, no. 18, pp. 2742–2747, 2014. View at Google Scholar
  25. O. Morris, X. Liu, C. Domingues et al., “Signal Integration by the IκB Protein Pickle Shapes Drosophila Innate Host Defense,” Cell Host and Microbe, vol. 20, no. 3, pp. 283–295, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. M.-Y. Gao, L. Chen, L. Yang, X. Yu, J.-P. Kou, and B.-Y. Yu, “Berberine inhibits LPS-induced TF procoagulant activity and expression through NF-κB/p65, Akt and MAPK pathway in THP-1 cells,” Pharmacological Reports, vol. 66, no. 3, pp. 480–484, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Zhong, K. Qian, J. Xiong, K. Ma, A. Wang, and Y. Zou, “Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-κB related signaling,” Biomedicine and Pharmacotherapy, vol. 83, pp. 302–313, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Zhang, Q. Sun, T. Xu et al., “Resveratrol attenuates the progress of liver fibrosis via the Akt/nuclear factor-κB pathways,” Molecular Medicine Reports, vol. 13, no. 1, pp. 224–230, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Ye, F. Y. L. Li, K. S. L. Lam et al., “Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice,” Gut, vol. 61, no. 7, pp. 1058–1067, 2012. View at Publisher · View at Google Scholar · View at Scopus